Reverse Type 1 Diabetes With A Raw Food Diet

Reverse type 1 diabetes with a raw food diet

(NaturalNews) Is it possible to reverse type 1 diabetes (T1D, previously known as insulin-dependent diabetes or IDDM) simply by enjoying a raw food diet? According to Dr. Kirt Tyson, a naturopathic doctor who practices in Arizona, eating a diet that primarily consists of raw foods can dramatically reduce blood sugar levels in type 1 diabetics, perhaps even stopping their insulin dependency.
How one doctor stopped his insulin dependence
Dr. Tyson speaks from experience. A former self-proclaimed fast food junkie and a type 1 diabetic himself, he now believes in the amazing power of eating raw.
During an interview with Robyn Openshaw, also known as Green Smoothie Girl and author of "12 Steps to Whole Foods," he revealed that, prior to starting a raw food diet, his blood sugar level was extremely high (diabetic ketoacidosis) at around 300 mg/dL. Anything above 240 mg/dL is cause for concern.
However, within 2-3 weeks of eating raw foods - nuts, seeds and vegetables with no dairy, meat or fruits - he checked his blood sugar again. The unbelievable result? His blood sugar level dropped to an acceptable, safe range: 76 mg/dL. Today, he says he only needs insulin if he becomes sick (which causes blood sugar levels to rise).
Raw foods: what's best for diabetics?
The American Diabetes Association's website lists top super foods for diabetics. Among them are nuts and seeds such as walnuts and flax, as well as vegetables - the darker and leafier, the better. These suggestions align with the raw food diet lifestyle that worked for Dr. Tyson.
Other diabetics following a raw food diet oft Continue reading

Rate this article

Total 1 ratings

The Frozen Shoulder: What's Diabetes Got to Do With It?

Adhesive capsulitis—commonly known as frozen shoulder—can make routine activities like getting dressed and changing your insulin pump, nearly impossible. It is the the most prevalent upper body musculoskeletal injury in people with diabetes. Learn more.
Adhesive casulitis, also known as frozen should, is a rheumatic condition which can leave you unable to reach above your head or behind your back. It results from inflammatory changes in the connective tissue of an area called the shoulder capsule. Over time, the tissue can thicken and become tight. Stiff bands of tissue called adhesions develop, making movement of the joint painful and even blocking the shoulder joint’s normal range of motion.
Eventually the shoulder becomes extremely stiff and extremely painful to move, as if it’s “frozen” in place. If you wear an insulin pump, this condition can be especially challenging.
DiabeticLifestyle Editorial Board Member Amy Hess Fischl, MS, RD, LDN, BC-ADM, CDE says she’s worked with several type 1 women diagnosed with frozen shoulder. “One of my patients who had long used an insulin pump, had to switch back to insulin injections until her shoulder issue resolved since inserting infusion sets was too difficult,” Hess Fischl explained. “Fortunately, she was able to resume her insulin pump after several months of regular physical therapy but in the interim more frequent communication was required between us to help her adjust her insulin doses to account for the pain, reduced sleep and less activity.”
There are two types of adhesive capsulitis.In the first, th Continue reading

Harnessing immunotherapy to reverse Type 1 diabetes

In patients with Type 1 diabetes, T cells in the immune system mistakenly attack islet cells in the pancreas that make insulin. Scientists at Boston Children’s Hospital have come up with a way to thwart this wayward autoimmune reaction, and it involves a protein that plays a prominent role in new immunotherapy treatments for cancer: PD-L1.
PD-L1 is called an immune “checkpoint” because it prevents T cells from recognizing and attacking cancer. Drugs that inhibit PD-L1, like Genentech’s Tecentriq, have proven effective for fighting some cancers. But the Boston Children’s researchers believe that in diabetes, PD-L1 may actually need to be boosted. That’s because the protein appears to be instrumental in crippling the “autoreactive” T cells that destroy insulin-producing cells.
The researchers tested their theory by pre-treating blood stem cells so they would produce excess PD-L1 and then infusing them into mouse models of diabetes. The treated stem cells sped towards the pancreas, curing almost all of the mice of diabetes in the short term, according to a press release. About 30% of the animals remained diabetes-free for the duration of their lives. The research was published in the journal Science Translational Medicine.
The idea of using blood stem cells to reverse diabetes isn’t new. In fact, bone marrow transplants have been tried in diabetes patients, but they haven’t been uniformly effective. The Boston Children’s team wanted to find out why, so they set out to profile all the proteins made by blood stem cells from diabetic people and mice.
They di Continue reading

No overnight cure for type 1 diabetes – but closed loops offer respite

While a beta cell replacement therapy is the dream of all type 1 patients, new medical devices are hitting the market, and promise more peace of mind. However US patients could find access to these innovations restricted; Richard Staines reports from the American Diabetes Association 2017 conference in San Diego.
Patients living with type 1 diabetes (T1D) and their families have to live with their disease and be mindful of its dangers 24/7 – not just when they are awake, but also when they are asleep.
The risk of night-time hypoglycaemia remains a constant worry, especially for parents with children who have the condition – and this is one of the driving forces for new technological solutions to the problem – and indeed an outright cure for the condition.
One of key debates about the future direction of T1D treatment hinges on this question: will technological solutions such as an artificial pancreas or a ‘closed loop’ system (insulin pumps combined with continuous glucose monitoring) be the answer, or is a cure via beta cell replacement therapy on the horizon?
The short answer is that closed loop systems are here today, and are already proving their value.
Research from two small studies presented at this year’s American Diabetes Association conference have shown that closed loop systems can help prevent hypoglycaemia in children and adults.
The combination of continuous glucose monitoring (CGM) systems with insulin pumps allows constant management of the disease – described by some as a step towards an “artificial pancreas”.
Medtronic’s MiniMed 670G cl Continue reading

Gore joins ViaCyte’s quest for a functional type 1 diabetes cure

A cure for type 1 diabetes has been “just around the corner” for decades now — or so patients have been told. But the moonshot mission has been rough.
ViaCyte knows this well after years 18 years of R&D. With every step of progress, a new mountain of challenges looms. The company puts its head down and troubleshoots through, with backing from private investors, pharma partners, the California Institute for Regenerative Medicine (CIRM) and the Juvenile Diabetes Research Fund (JDRF).
On Wednesday, the San Diego, California-based company announced a new partner; W. L. Gore & Associates, the multi-billion dollar manufacturer of medical and non-medical fabrics and devices, including the iconic GORE-TEX. If Gore can contribute some materials expertise, one more problem could get solved.
The partnership centers around ViaCyte’s flagship islet replacement therapy.
Type 1 diabetes (aka juvenile diabetes) is an autoimmune disease. It accounts for around 5 percent of all diabetes cases. Some 95 percent are caused by so-called adult-onset diabetes, which is a longer-term metabolic disorder.
While genetic and environmental factors are believed to play a role, the ultimate trigger for type 1 diabetes is not known. At some point, the immune system incorrectly recognizes beta cells in the pancreas as foreign or threatening. It begins systematically destroying them and with that, the ability of the body to produce insulin.
Insulin is the key that allows glucose to enter cells. Without insulin, glucose builds up in the bloodstream while cells are effectively being starved. For decade Continue reading